Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 0.2% on Friday.
美国股票期货今天早上高开，纳斯达克期货周五上涨约0.2%。
Shares of NIKE, Inc. (NYSE:NKE) fell sharply in today's pre-market trading following fourth-quarter earnings and soft FY25 guidance.
NIKE股份有限公司（纽约证券交易所：NKE）在今天盘前交易中由于第四季度盈利和软弱的FY25指引而大幅下跌。
Analysts at Stifel and Morgan Stanley downgraded the stock following the report.
斯蒂费尔和大摩资源lof的分析师在报告后调降了这支股票的评级。
NIKE shares dipped 15.6% to $79.42 in pre-market trading.
NIKE股价在盘前交易中下跌了15.6%，至79.42美元。
Here are some big stocks recording losses in today's pre-market trading session.
以下是在今天美股盘前交易中录得下跌的一些大型股票。
- Accolade, Inc. (NASDAQ:ACCD) shares tumbled 32.1% to $4.34 in pre-market trading after the company reported first-quarter financial results and issued worse-than-expected FY25 revenue guidance. Also, Needham maintained a Buy rating on the stock but lowered its price target from $13 to $8.
- PTC Therapeutics, Inc. (NASDAQ:PTCT) shares slipped 13.5% to $30.00 in pre-market trading after the company said CHMP has issued negative opinion on renewal of conditional marketing authorization of Translarna (Ataluren) for the treatment of nmDMD.
- Kura Sushi USA, Inc. (NASDAQ:KRUS) shares declined 12.4% to $72.00 in pre-market trading after the company issued soft guidance.
- Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) shares fell 12.4% to $18.75 in pre-market trading. The company announced the FDA issued a Complete Response Letter for the License Application For KRESLADI and requested limited additional Chemistry Manufacturing and Controls information to complete its review.
- Polestar Automotive Holding UK PLC (NASDAQ:PSNY) fell 7.7% to $0.7613 in pre-market trading after the company published full year 2023 results.
- Foot Locker, Inc. (NYSE:FL) shares fell 5.3% to $24.16 in pre-market trading.
- Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) shares declined 4.1% to $39.84 in pre-market trading. Apellis plans to seek re-examination following negative CHMP opinion for pegcetacoplan for geographic atrophy (GA) in the EU.
- Accolade股份有限公司（纳斯达克：ACCD）周一在盘前交易中股价暴跌32.1%，每股股价为4.34美元，此前该公司发布了第一季度财务业绩和比预期更差的FY25营收指引。同时，Needham对该股票维持买入评级，但将其目标价从13美元下调至8美元。
- PTC Therapeutics股份有限公司（纳斯达克：PTCT）股票在盘前交易中下跌13.5%，至30.00美元，此前该公司表示CHMP对Translarna（Ataluren）治疗nmDMD的条件性营销授权续期发出了否定意见。
- Kura Sushi USA股份有限公司（纳斯达克：KRUS）股票在盘前交易中下跌12.4%，至72.00美元，此前该公司发出了软指引。
- Rocket Pharmaceuticals股份有限公司（纳斯达克：RCKT）股票在盘前交易中下跌12.4%，至18.75美元，该公司宣布FDA对KRESLADI的许可申请发出了完整的回应信，并要求提供有限的其他化学制备和控制信息以完成审核。
- Polestar Automotive Holding UK股份有限公司（纳斯达克：PSNY）股票在盘前交易中下跌7.7%，至0.7613美元，此前该公司公布了2023年全年业绩。
- Foot Locker股份有限公司（纽约证券交易所：FL）在盘前交易中下跌了5.3%，至24.16美元。
- Apellis Pharmaceuticals股份有限公司（纳斯达克：APLS）股票在盘前交易中下跌了4.1%，至39.84美元。Apellis计划在收到欧盟地理性萎缩（GA）的pegcetacoplan的负面CHMP意见后寻求复审。
Now Read This: IZEA Worldwide And 2 Other Stocks Under $3 Insiders Are Buying
IZEA Worldwide和其他两个股票都在3美元以下，内部人正在买入
Don't forget to check out our premarket coverage here
别忘了查看我们的盘前报道。